LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
Lead development candidate selected by Janssen Biotech under research collaboration provides a milestone payment to LAVAStrong balance sheet expected to provide cash runway into 2026 UTRECHT, The... | June 8, 2023